BioSpace News Archive

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that on August 8, 2022, after the U.S. financial markets closed, we received a communication from the U.S. Food and Drug Administration informing us that they have extended the review timeline for the New Drug Application for omaveloxolone for the treatment of Friedreich’s ataxia by three months.

Inmagene Biopharmaceutical and HUTCHMED Limited announce that the first participant, based in the United States, was dosed in a global Phase I trial of IMG-004, a non-covalent, reversible, third-generation Bruton Tyrosine Kinase inhibitor.

The global hepatitis diagnostic test market is prognosticated to witness a surge in its demand during the forecast period 2018-2028.

The report details an exhaustive account of the global Crohn’s disease therapeutics market along with numerous associated factors.

Wilmington, Delaware, United States, Transparency Market Research Inc. – Transparency Market Research has published a new report titled “Drug Delivery System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global animal genetics market is expected to witness a CAGR of x% to reach ~US $ 8 Billion by the year 2026.

Wilmington, Delaware, United States, Transparency Market Research Inc. – Surge in prevalence of chronic injuries around the globe is expected to boost the expansion prospects in the global advance wound care market in the forecast period of 2021 to 2031.

Wilmington, Delaware, United States, Transparency Market Research Inc. – Transparency Market Research has published a new report titled, ‘Vascular Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Epizyme today reported second quarter 2022 financial results and provided a business update.

NeoGenomics, Inc. today announced its second-quarter results for the period ended June 30, 2022.